As of June 2026, 186 paid clinical trials are recruiting in Torrance, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Torrance offers studies at sites including Torrance Memorial Physician Network - Cancer Care for conditions such as Breast Cancer, Schizophrenia, Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Torrance has approximately 186 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Researchers run research studies in Torrance, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Torrance Memorial Physician Network - Cancer Care | Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 22 |
| City of Hope South Bay | Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer | 19 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Chronic Limb-Threatening Ischemia, Recurrent B Acute Lymphoblastic Leukemia, Adrenal Gland Pheochromocytoma | 15 |
| Torrance Memorial Medical Center | Acute Myocardial Infarction (AMI), Aortic Stenosis, Bacterial Infection | 7 |
| Harbor-UCLA Medical Center | Acute Major Bleeding, Diabetes Mellitus, Type 1, End-Stage Renal Disease | 6 |
| Neurocrine Clinical Site | Schizophrenia, Tardive Dyskinesia | 4 |
| The Lundquist Institute | ASCVD, ASCVD Management, Atherosclerosis Cardiovascular Disease | 4 |
| The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 4 |
| Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center | Acute Myocardial Infarction, Diabetes Mellitus, Type 2, Heart Failure | 4 |
| Collaborative Neuroscience Research, LLC | Bipolar Disorder Type I With Mania, Bipolar Disorder Type I With Mania or Mania With Mixed Features, Schizophrenia | 3 |
| Harbor UCLA Medical Center | Hepatocellular Carcinoma, Hypertension, Ketamine Infusion | 3 |
| Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center | Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities, Moderate Aortic Valve Stenosis, Peripheral Arterial Disease | 3 |
| Breathe Clear Institute | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Chronic Rhinosinusitis Without Nasal Polyps | 2 |
| CS Cancer at the Hunt Cancer Center | Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Carcinoma | 2 |
| City of Hope at South Bay | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 2 |
| GSK Investigational Site | Multiple Myeloma, Neoplasms, Head and Neck | 2 |
| Hunt Cancer Institute, an Affiliate of CS Cancer | Early Stage Triple-Negative Breast Carcinoma, TNBC, TNBC - Triple-Negative Breast Cancer | 2 |
| Macula Retina Vitreous Institute | Epiretinal Membrane, Neovascular Age-related Macular Degeneration | 2 |
| Macula Retina Vitreous Research Institute | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA), Neovascular Age-related Macular Degeneration | 2 |
| The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente | B-Cell Non-Hodgkins Lymphoma, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | 2 |
| Torrance Memorial Physicians Network | Colorectal Neoplasms | 2 |
| UCLA Hematology/Oncology - Torrance | Cancer of the Prostate, Hormone Sensitive Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC) | 2 |
| Genesis Research LLC | Non-muscle Invasive Bladder Cancer, Carcinoma in Situ, Non-Muscle Invasive Bladder Neoplasms | 2 |
| 603, Harbor University of California Los Angeles Center CRS | Acute HIV Infection | 1 |
| Abcentra Investigational Site | Acute Coronary Syndromes, Atherosclerotic Coronary Vascular Disease, Coronary Arterial Disease (CAD) | 1 |
Recruiting trials in Torrance grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Hipa.ai aggregates every recruiting study in Torrance from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 186 recruiting clinical trials in Torrance, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Torrance compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Torrance include Breast Cancer (7), Schizophrenia (6), Anatomic Stage II Breast Cancer AJCC v8 (5), Stage IV Lung Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Torrance on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Torrance include Torrance Memorial Physician Network - Cancer Care, City of Hope South Bay, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Torrance are Cancer & tumors (63), Cardiovascular (16), Mental health & behavior (11). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.